Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism

Cited by (1,006)

Items 301–400 of 1,006

1. Potent and Selective Covalent Quinazoline Inhibitors of KRAS G12C
   Zeng, Mei, Lu, Jia, Li, Lianbo, Feru, Frederic, Quan, Chunshan, Gero, Thomas W., Ficarro, Scott B., Xiong, Yuan, Ambrogio, Chiara, Paranal, Raymond M. et al. · 2017 · Cell Chemical Biology
2. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
   R. Brooks Robey, Judith Weisz, Nancy B. Kuemmerle, Anna C. Salzberg, Arthur S Berg, Dustin G. Brown, Laura L. Maurer, Roberta Palorini, Fahd Al‐Mulla, Rabeah Abbas Al-Temaimi et al. · 2015 · Carcinogenesis
3. Tumour microenvironment responsive nanoconstructs for cancer theranostic
   Arif Gulzar, Jiating Xu, Chen Wang, Fei He, Dan Yang, Shili Gai, Piaoping Yang, Jun Lin, Dayong Jin, Bengang Xing · 2019 · Nano Today
4. MAPK signaling is required for dedifferentiation of acinar cells and development of pancreatic intraepithelial neoplasia in mice
   Collins, Meredith A., Yan, Wei, Sebolt–Leopold, Judith S., Pasca di Magliano, Marina · 2014 · Gastroenterology
5. A CRISPR-Cas13a system for efficient and specific therapeutic targeting of mutant KRAS for pancreatic cancer treatment
   Xiao Zhao, Liang Liu, Jiayan Lang, Keman Cheng, Yongwei Wang, Xueyan Li, Jian Ying Shi, Yanli Wang, Guangjun Nie · 2018 · Cancer Letters
6. Characterization of Glycolysis-Associated Molecules in the Tumor Microenvironment Revealed by Pan-Cancer Tissues and Lung Cancer Single Cell Data
   Jinfen Wei, Kaitang Huang, Meiling Hu, Zixi Chen, Yunmeng Bai, Shudai Lin, Hongli Du · 2020 · Cancers
7. Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
   Mark L. McCleland, Adam S. Adler, Laura Deming, Ely Cosino, Leslie B. Lee, Elizabeth M. Blackwood, Margaret Solon, Janet Tao, Li Li, David S. Shames et al. · 2012 · Clinical Cancer Research
8. Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets
   Martin C. Whittle, Sunil R. Hingorani · 2019 · Gastroenterology
9. Cancer metabolism and tumor microenvironment: fostering each other?
   Yiyuan Yuan, Huimin Li, Pu Wang, Leilei Chen, Dong Sheng Guo, Hongfei Jiang, Bo He, Siyuan Qin, Kui Wang, Na Li et al. · 2021 · Science China Life Sciences
10. Ornithine aminotransferase supports polyamine synthesis in pancreatic cancer
    Min-Sik Lee, Courtney Dennis, Insia Naqvi, Lucas Dailey, Alireza Lorzadeh, George Ye, Tamara Zaytouni, Ashley Adler, Daniel S. Hitchcock, Lin Lin et al. · 2023 · Nature
11. PI3K Regulation of RAC1 Is Required for KRAS-Induced Pancreatic Tumorigenesis in Mice
    Chia-Yen C. Wu, Eileen S. Carpenter, Kenneth K. Takeuchi, Christopher J. Halbrook, Louise V. Peverley, Harold Bien, Jason C. Hall, Kathleen E. DelGiorno, Debjani Pal, Yan Song et al. · 2014 · Gastroenterology
12. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth
    Susanna Raho, Loredana Capobianco, Rocco Malivindi, Angelo Vozza, Carmela Piazzolla, Francesco De Leonardis, Ruggiero Gorgoglione, Pasquale Scarcia, Francesca Pezzuto, Gennaro Agrimi et al. · 2020 · Nature Metabolism
13. Targeting metabolic reprogramming in KRAS-driven cancers
    Kenji Kawada, Kosuke Toda, Yoshiharu Sakai · 2017 · International Journal of Clinical Oncology
14. The biological underpinnings of therapeutic resistance in pancreatic cancer
    Gregory Lawrence Beatty, Gregor Werba, Costas Andreas Lyssiotis, Diane M. Simeone · 2021 · Genes & Development
15. Metabolism addiction in pancreatic cancer
    Roy Blum, Yoel Kloog · 2014 · Cell Death and Disease
16. GEMMs as preclinical models for testing pancreatic cancer therapies
    Aarthi Gopinathan, Jennifer P. Morton, Duncan Ian Jodrell, Owen James Sansom · 2015 · Disease Models & Mechanisms
17. Targeting RAS -mutant Cancers: Is ERK the Key?
    Meagan B. Ryan, Channing J. Der, Andrea Wang‐Gillam, Adrienne D. Cox · 2015 · Trends in cancer
18. Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone
    Gaurab Chakrabarti, Zachary Moore, Xiuquan Luo, Mariya Ilcheva, Aktar Ali, Mahesh S. Padanad, Yunyun Zhou, Yang Xie, Sandeep Burma, Pier Paolo Scaglioni et al. · 2015 · Cancer & Metabolism
19. Oncogenic KRAS and BRAF Drive Metabolic Reprogramming in Colorectal Cancer
    Josiah E. Hutton, Xiaojing Wang, Lisa J. Zimmerman, Robbert J.C. Slebos, Irina A. Trenary, Jamey D. Young, Ming Li, Daniel C. Liebler · 2016 · Molecular & Cellular Proteomics
20. High Glucose Triggers Nucleotide Imbalance through O-GlcNAcylation of Key Enzymes and Induces KRAS Mutation in Pancreatic Cells
    Hu, Chun-Mei, Tien, Sui-Chih, Hsieh, Ping-Kun, Jeng, Yung-Ming, Chang, Ming-Chu, Chang, Yu-Ting, Chen, Yi-Ju, Chen, Yu-Ju, Lee, Eva Y.-H.P., Lee, Wen-Hwa · 2019 · Cell Metabolism
21. Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
    Rana Rais, Kathryn M. Lemberg, Lukáš Tenora, Matthew L. Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H. Aguilar, Liang Zhao et al. · 2022 · Science Advances
22. Therapeutic options for the management of pancreatic cancer
    Maria L Rossi · 2014 · World Journal of Gastroenterology
23. Global Profiling Strategies for Mapping Dysregulated Metabolic Pathways in Cancer
    Daniel I. Benjamin, Benjamin F. Cravatt, Daniel K. Nomura · 2012 · Cell Metabolism
24. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context
    Kerk, Samuel A, Lin, Lin, Myers, Amy L, Sutton, Damien J, Andren, Anthony, Sajjakulnukit, Peter, Zhang, Li, Zhang, Yaqing, Jiménez, Jennifer A, Nelson, Barbara S et al. · 2022 · eLife
25. Amplification of USP13 drives ovarian cancer metabolism
    Cecil Han, Lifeng Yang, Hyun Ho Choi, Joelle Baddour, Abhinav Achreja, Yunhua Liu, Yujing Li, Jia‐Da Li, Guohui Wan, Cheng Huang et al. · 2016 · Nature Communications
26. Dependence on the Pyrimidine Biosynthetic Enzyme DHODH Is a Synthetic Lethal Vulnerability in Mutant KRAS-Driven Cancers
    Malvika Koundinya, Judith Sudhalter, Albane Courjaud, Bruno Lionne, Gaetan Touyer, Luc Bonnet, Isabelle Menguy, Isabelle Schreiber, Christelle Perrault, Stéphanie Vougier et al. · 2018 · Cell chemical biology
27. Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation
    Kathleen A. Boyle, Jonathan Van Wickle, R. Blake Hill, Adriano Marchese, Balaraman Kalyanaraman, Michael B. Dwinell · 2018 · Journal of Biological Chemistry
28. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate
    Chi Chun Wong, Yun Qian, Xiaona Li, Jiaying Xu, Wei Kang, JOANNA H.M. TONG, Ka‐Fai To, Jin Ye, Weilin Li, Huarong Chen et al. · 2016 · Gastroenterology
29. mTORC2 Responds to Glutamine Catabolite Levels to Modulate the Hexosamine Biosynthesis Enzyme GFAT1
    Joseph Gennaro Moloughney, Peter K. Kim, Nicole M. Vega-Cotto, Chang‐Chih Wu, Sisi Zhang, Matthew Adlam, Thomas P. Lynch, Po-Chien Chou, Joshua D. Rabinowitz, Guy Werlen et al. · 2016 · Molecular Cell
30. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis
    Jia Zhang, Su Wang, Bin Jiang, Lihong Huang, Z. Ji, Xiaotong Li, Hua-Min Zhou, A. Han, Ai Chen, Yanan Wu et al. · 2017 · Nature Communications
31. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies
    Christine Lam, Jin‐Yih Low, Phuoc Tho Tran, Hailun Wang · 2021 · Cancer Letters
32. Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer
    Ran Li, Thomas S.C. Ng, Stephanie J. Wang, Mark Prytyskach, Christopher B. Rodell, Hannes Mikula, Rainer H. Köhler, Michelle A. Garlin, Douglas A. Lauffenburger, Sareh Parangi et al. · 2021 · Nature Nanotechnology
33. Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
    Jeffrey A. Klomp, Jennifer E. Klomp, Clint A. Stalnecker, Kirsten L. Bryant, A. Cole Edwards, Kristina Drizyte‐Miller, Priya S. Hibshman, J. Nathaniel Diehl, Ye S. Lee, Alexis Jean Morales et al. · 2024 · Science
34. Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons
    Anna A. Shvedova, Naveena V. K. Yanamala, Elena R. Kisin, Alexey V. Tkach, Ashley R. Murray, Ann F. Hubbs, Madalina M. Chirila, Phouthone Keohavong, Lyudmila P. Sycheva, Valerian E. Kagan et al. · 2013 · American Journal of Physiology-Lung Cellular and Molecular Physiology
35. The sweet trap in tumors: aerobic glycolysis and potential targets for therapy
    Li Yu, Xun Chen, Liantang Wang, Shangwu Chen · 2016 · Oncotarget
36. Biological determinants of radioresistance and their remediation in pancreatic cancer
    Parthasarathy Seshacharyulu, Michael J. Baine, Joshua J. Souchek, Melanie Menning, Sukhwinder Kaur, Ying Yan, Michel M. Ouellette, Maneesh Jain, Chi H. Lin, Surinder K. Batra · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
37. Pancreatic Cancer: Molecular Characterization, Clonal Evolution and Cancer Stem Cells
    Elvira Pelosi, Germana Castelli, Ugo Testa · 2017 · Biomedicines
38. HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer
    Holly Brunton, Giuseppina Caligiuri, Richard Cunningham, Rosanna Upstill‐Goddard, Ulla‐Maja Bailey, Ian Garner, Craig Nourse, Stephan B. Dreyer, Marc D. Jones, Kim Moran‐Jones et al. · 2020 · Cell Reports
39. Pancreatic cancer-derived exosomes promote tumor metastasis and liver pre-metastatic niche formation
    Zeqian Yu, Susu Zhao, Long Fang Ren, Lishan Wang, Zhangjun Chen, Robert M. Hoffman, Jiahua Zhou · 2017 · Oncotarget
40. Glucose Metabolism in Pancreatic Cancer
    Yan Liang, P. Shalem Raj, Wantong Yao, Haoqiang Ying · 2019 · Cancers
41. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer
    Tobiloba E. Oni, Giulia Biffi, Lindsey A. Baker, Hao Yuan, Claudia Tonelli, Tim D.D. Somerville, Astrid Deschênes, Pascal Belleau, Chang‐Il Hwang, Francisco J. Sánchez Rivera et al. · 2020 · The Journal of Experimental Medicine
42. Modulation of the proteostasis network promotes tumor resistance to oncogenic KRAS inhibitors
    Lv, Xiangdong, Lu, Xuan, Cao, Jin, Luo, Qin, Ding, Yao, Peng, Fanglue, Pataer, Apar, Lu, Dong, Han, Dong, Malmberg, Eric et al. · 2023 · Science
43. Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma
    Kang Sun, Xiaozhen Zhang, Jiatao Shi, Jinyan Huang, Sicheng Wang, Xiang Li, Haixiang Lin, Danyang Zhao, Mao Ye, Sirui Zhang et al. · 2025 · Journal of Clinical Investigation
44. Potential mechanisms of CD133 in cancer stem cells
    Jae-Woo Jang, Yeonhwa Song, Se-Hyuk Kim, Joon Kim, Haeng Ran Seo · 2017 · Life Sciences
45. IL6 Mediates Suppression of T- and NK-cell Function in EMT-associated TKI-resistant EGFR-mutant NSCLC
    Sonia A. Patel, Monique B. Nilsson, Yan Yang, Xiuning Le, Hai Thanh Tran, Yasir Y. Elamin, Xiaoxing Yu, Fahao Zhang, Alissa Poteete, Xiaoyang Ren et al. · 2023 · Clinical Cancer Research
46. Current State and Future Challenges for PI3K Inhibitors in Cancer Therapy
    Sirico, Marianna, D’Angelo, Alberto, Gianni, Caterina, Casadei, Chiara, Merloni, Filippo, De Giorgi, Ugo · 2023 · Cancers
47. Targeting cancer cell metabolism in pancreatic adenocarcinoma
    Romain Cohen, Cindy Neuzillet, Annemilaï Tijeras‐Raballand, Sandrine J. Faivre, Armand D.E. Gramont, Éric Raymond · 2015 · Oncotarget
48. Stromal reengineering to treat pancreas cancer
    Ingunn M. Stromnes, Kathleen E. DelGiorno, Philip D. Greenberg, Sunil R. Hingorani · 2014 · Carcinogenesis
49. The complex landscape of pancreatic cancer metabolism
    C. M. Sousa, Alec C. Kimmelman · 2014 · Carcinogenesis
50. Quantitative Super-Resolution Microscopy of the Mammalian Glycocalyx
    Leonhard Möckl, Kayvon Pedram, Anish R. Roy, Venkatesh Krishnan, Anna‐Karin Gustavsson, Oliver Dorigo, Carolyn Ruth Bertozzi, W. E. Moerner · 2019 · Developmental Cell
51. Computer-aided drug repurposing for cancer therapy: Approaches and opportunities to challenge anticancer targets
    Carla Mottini, Francesco Napolitano, Zhongxiao Li, Xin Gao, Luca Cardone · 2019 · Seminars in Cancer Biology
52. Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer
    Edward B. Garon, Heather R. Christofk, Wylie Hosmer, Carolyn D. Britten, Agnes Y. Bahng, Matthew Crabtree, Candice Sun Hong, Naeimeh Kamranpour, Sharon L. Pitts, Fairooz F. Kabbinavar et al. · 2014 · Journal of Cancer Research and Clinical Oncology
53. Cancer-associated fibroblasts reuse cancer-derived lactate to maintain a fibrotic and immunosuppressive microenvironment in pancreatic cancer
    Kitamura, Fumimasa, Semba, Takashi, Yasuda-Yoshihara, Noriko, Yamada, Kosuke, Nishimura, Akiho, Yamasaki, Juntaro, Nagano, Osamu, Yasuda, Tadahito, Yonemura, Atsuko, Tong, Yilin et al. · 2023 · JCI Insight
54. Genome-Wide CRISPR Screen for Essential Cell Growth Mediators in Mutant KRAS Colorectal Cancers
    Edwin H. Yau, Indrasena Reddy Kummetha, Gianluigi Lichinchi, Rachel Tang, Yunlin Zhang, Tariq M. Rana · 2017 · Cancer Research
55. Metabolic Regulation of Redox Balance in Cancer
    Vinee Purohit, Diane M. Simeone, Costas Andreas Lyssiotis · 2019 · Cancers
56. Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions
    Maximilian Brunner, Z. Wu, Christian Krautz, Christian P. Pilarsky, Robert Grützmann, Georg F. Weber · 2019 · International Journal of Molecular Sciences
57. Dysregulation of mitophagy in carcinogenesis and tumor progression
    Joon Young Chang, Hyon‐Seung Yi, Hyeon-Woo Kim, Minho Shong · 2016 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
58. Oncogenes and tumor suppressor genes: functions and roles in cancers
    Tikam Chand Dakal, Bhanupriya Dhabhai, Anuja Pant, Kareena Moar, Kanika Chaudhary, Vikas Yadav, Vipin Ranga, Narendra Kumar Sharma, Abhishek Kumar, Pawan Kumar Maurya et al. · 2024 · MedComm
59. eIF4A supports an oncogenic translation program in pancreatic ductal adenocarcinoma
    Chan, Karina, Robert, Francis, Oertlin, Christian, Kapeller-Libermann, Dana, Avizonis, Daina, Gutierrez, Johana, Handly-Santana, Abram, Doubrovin, Mikhail, Park, Julia, Schoepfer, Christina et al. · 2019 · Nature Communications
60. Epithelial and stromal co-evolution and complicity in pancreatic cancer
    Hingorani, Sunil R. · 2023 · Nature Reviews Cancer
61. Complete regression of advanced pancreatic ductal adenocarcinomas upon combined inhibition of EGFR and C-RAF
    Blasco, María Teresa, Navas, Carolina, Martín-Serrano, Guillermo, Graña-Castro, Osvaldo, Lechuga, Carmen G., Martín-Díaz, Laura, Djurec, Magdolna, Li, Jing, Morales-Cacho, Lucia, Esteban-Burgos, Laura et al. · 2019 · Cancer Cell
62. Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation
    Guannan Li, Xuejiao Zhao, Zhen Wang, Meng-Shi Luo, Shen-Nan Shi, Danmei Yan, Huayi Li, Jiahao Liu, Yang Yang, Jiahong Tan et al. · 2022 · Signal Transduction and Targeted Therapy
63. Gas‐Mediated Tumor Energy Remodeling for Sensitizing Mild Photothermal Therapy
    Junjie Cheng, Yang Zhu, Yiping Dai, Li Li, Miya Zhang, Duo Jin, Manman Liu, Jiaji Yu, Wenxin Yu, Dan Su et al. · 2023 · Angewandte Chemie International Edition
64. IL1 Receptor Antagonist Inhibits Pancreatic Cancer Growth by Abrogating NF-κB Activation
    Zhuonan Zhuang, Huai‐Qiang Ju, Mitzi Aguilar, Takashi Gocho, Hao Li, Tomonori Iida, Harold Lee, Xiaoqiang Fan, Haijun Zhou, Jianhua Ling et al. · 2015 · Clinical Cancer Research
65. Kras as a key oncogene and therapeutic target in pancreatic cancer
    Meredith A. Collins, Marina Pasca di Magliano · 2014 · Frontiers in Physiology
66. Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
    Huanan Wang, Lei Wang, Yingjie Zhang, Ji Wang, Yibin Deng, Degui Lin · 2016 · Cancer Cell International
67. Metabolic Alterations Caused by KRAS Mutations in Colorectal Cancer Contribute to Cell Adaptation to Glutamine Depletion by Upregulation of Asparagine Synthetase
    Kosuke Toda, Kenji Kawada, Masayoshi Iwamoto, Susumu Inamoto, Takehiko Sasazuki, Senji Shirasawa, Suguru Hasegawa, Yoshiharu Sakai · 2016 · Neoplasia
68. Tumor metabolic regulators: key drivers of metabolic reprogramming and the promising targets in cancer therapy
    Kun Huang, Ying Han, Yihong Chen, Hong Shen, Shan Zeng, Changjing Cai · 2025 · Molecular Cancer
69. A nexus for cellular homeostasis: the interplay between metabolic and signal transduction pathways
    Gomes, Ana P, Blenis, John · 2015 · Current Opinion in Biotechnology
70. Role and regulation of coordinately expressedde novopurine biosynthetic enzymesPPATandPAICSin lung cancer
    Moloy T. Goswami, Guoan Chen, Balabhadrapatruni V. S. K. Chakravarthi, Satya S. Pathi, Sharath Kumar Anand, Shannon L. Carskadon, Thomas J. Giordano, Arul M. Chinnaiyan, Dafydd G. Thomas, Nallasivam Palanisamy et al. · 2015 · Oncotarget
71. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes
    Anna Melissa Schlitter, Angela Segler, Katja Steiger, Christoph W. Michalski, Carsten Jäger, Björn Konukiewitz, Nicole Pfarr, Volker Endris, Markus Bettstetter, Bo Kong et al. · 2017 · Scientific Reports
72. Nuclear Glycogenolysis Modulates Histone Acetylation in Human Non-Small Cell Lung Cancers
    Ramon C. Sun, Vikas V. Dukhande, Zhengqiu Zhou, Lyndsay E.A. Young, Shane Emanuelle, Christine F. Brainson, Matthew S. Gentry · 2019 · Cell Metabolism
73. Heterocellular OSM-OSMR signalling reprograms fibroblasts to promote pancreatic cancer growth and metastasis
    Brian Yong Lee, Elizabeth K. J. Hogg, Christopher Below, Alexander Kononov, Adrián Blanco‐Gómez, Felix Heider, Jingshu Xu, Colin Hutton, Xiaohong Mary Zhang, Tamara Scheidt et al. · 2021 · Nature Communications
74. Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1
    Nathaniel Weygant, Dongfeng Qu, William L. Berry, Randal J. May, Parthasarathy Chandrakesan, Daniel B. Owen, Sripathi M. Sureban, Naushad Ali, Ralf Janknecht, Courtney W. Houchen · 2014 · Molecular Cancer
75. Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
    Neus Martínez‐Bosch, Maite G. Fernández‐Barrena, Mireia Moreno, Elena Ortiz Zapater, Jessica Munné‐Collado, Mar Iglesias, Sabine André, Hans‐Joachim Gabius, Rosa F. Hwang, Françoise Poirier et al. · 2014 · Cancer Research
76. The Central Role of Amino Acids in Cancer Redox Homeostasis: Vulnerability Points of the Cancer Redox Code
    Milica Vučetić, Yann Cormerais, Scott K. Parks, Jacques Pouysségur · 2017 · Frontiers in Oncology
77. Branched-chain amino acids sustain pancreatic cancer growth by regulating lipid metabolism
    Ji Hyeon Lee, Young-Ra Cho, Ji Hye Kim, Jong-Wook Kim, Hae Yun Nam, Seong Who Kim, Jaekyoung Son · 2019 · Experimental & Molecular Medicine
78. Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways
    Min Li, Xuxiao He, Wei‐Xing Guo, Hongming Yu, Shicheng Zhang, Ningning Wang, Guijun Liu, Rina Sa, Xia Shen, Yabo Jiang et al. · 2020 · Nature Cancer
79. Endothelial cell metabolism: parallels and divergences with cancer cell metabolism
    Dries Verdegem, Stijn Moens, Peter Conrad Stapor, Peter Carmeliet · 2014 · Cancer & Metabolism
80. The emerging roles of microRNAs in cancer metabolism
    Brian Chan, Jacob Manley, Jae Lee, Shree Ram Singh · 2014 · Cancer Letters
81. CD4+ T lymphocyte ablation prevents pancreatic carcinogenesis in mice
    Zhang, Yaqing, Yan, Wei, Mathew, Esha, Bednar, Filip, Wan, Shanshan, Collins, Meredith A., Evans, Rebecca A., Welling, Theodore H., Vonderheide, Robert H., di Magliano, Marina Pasca · 2014 · Cancer Immunology Research
82. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine
    Erik S. Knudsen, Eileen Mary O'Reilly, Jonathan Robert Brody, Agnieszka Katarzyna Witkiewicz · 2015 · Gastroenterology
83. Mutant Kras co-opts a proto-oncogenic enhancer network in inflammation-induced metaplastic progenitor cells to initiate pancreatic cancer
    Yong Li, Yi He, Junya Peng, Zhendong Su, Zeyao Li, Bingjie Zhang, Jing Ma, Meilian Zhuo, Di Zou, Xinde Liu et al. · 2020 · Nature Cancer
84. Glutaminase and poly(ADP-ribose) polymerase inhibitors suppress pyrimidine synthesis and VHL-deficient renal cancers
    Arimichi Okazaki, Paulo A. Gameiro, Danos C. Christodoulou, Laura A. Laviolette, Meike Schneider, Frances L. Chaves, Anat O Stemmer-Rachamimov, Stephanie A. Yazinski, Richard E. Lee Jr., Gregory N Stephanopoulos et al. · 2017 · Journal of Clinical Investigation
85. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition
    Seungyeon Yang, Sunsook Hwang, Minjoong Kim, Sung Bin Seo, Jeong‐Hwa Lee, Seung Min Jeong · 2018 · Cell Death and Disease
86. Translating complexity and heterogeneity of pancreatic tumor: 3D in vitro to in vivo models
    Marcel Alexander Heinrich, Ahmed M. R. H. Mostafa, Jennifer P. Morton, Lukas J.A.C. Hawinkels, Jai Prakash · 2021 · Advanced Drug Delivery Reviews
87. O-GlcNAcylation promotes pancreatic tumor growth by regulating malate dehydrogenase 1
    Qiang Zhu, Hong Zhou, Liming Wu, Zhenyuan Lai, Didi Geng, Weiwei Yang, Jie Zhang, Zhiya Fan, Weijie Qin, Yong Wang et al. · 2022 · Nature Chemical Biology
88. Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
    Irem Ozkan‐Dagliyan, J. Nathaniel Diehl, Samuel D. George, Antje Schaefer, Bjoern Papke, Kathleen Klotz‐Noack, Andrew M. Waters, Craig M. Goodwin, Prson Gautam, Mariaelena Pierobon et al. · 2020 · Cell Reports
89. Ras inhibition via direct Ras binding—is there a path forward?
    Weiru Wang, G. Fang, Joachim Rudolph · 2012 · Bioorganic & Medicinal Chemistry Letters
90. Transforming growth factor beta‐induced, an extracellular matrix interacting protein, enhances glycolysis and promotes pancreatic cancer cell migration
    Brunella Costanza, Gilles Rademaker, Assia Tiamiou, Pascal De Tullio, Justine Leenders, Arnaud Blomme, Justine Bellier, Elettra Bianchi, Andrei Turtoï, Philippe Delvenne et al. · 2019 · International Journal of Cancer
91. Targeting KRAS in pancreatic cancer: new drugs on the horizon
    Sahar F. Bannoura, Md. Hafiz Uddin, Misako Nagasaka, Farzeen Fazili, Mohammed Najeeb Al Hallak, Philip A. Philip, Bassel F. El‐Rayes, Asfar Sohail Azmi · 2021 · Cancer and Metastasis Reviews
92. Critical role for arginase 2 in obesity-associated pancreatic cancer
    Tamara Zaytouni, Pei-Yun Tsai, Daniel S. Hitchcock, Cory D. DuBois, Elizaveta Freinkman, Lin Lin, Vicente Morales‐Oyarvide, Patrick J. Lenehan, Brian Matthew Wolpin, Mari A. Mino-Kenudson et al. · 2017 · Nature Communications
93. ATP-binding cassette transporters in progression and clinical outcome of pancreatic cancer: What is the way forward?
    Aleksandra Adamska, Marco Falasca · 2018 · World Journal of Gastroenterology
94. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis
    Xialin Luo, Jingjing Liu, Huaizhi Wang, Haitao Lu · 2020 · Pharmacological Research
95. The Hallmarks of Cancer from a Redox Perspective
    Marten Hornsveld, Tobias B. Dansen · 2016 · Antioxidants and Redox Signaling
96. Targeting tumor mitochondrial metabolism overcomes resistance to antiangiogenics
    Navarro, Paloma, Bueno, Maria J., Zagorac, Ivana, Mondejar, Tamara, Sanchez, Jesus, Mourón, Silvana, Muñoz, Javier, Gómez-López, Gonzalo, Jimenez-Renard, Veronica, Mulero, Francisca et al. · 2016 · Cell Reports
97. Metabolic Reprogramming for Producing Energy and Reducing Power in Fumarate Hydratase Null Cells from Hereditary Leiomyomatosis Renal Cell Carcinoma
    Youfeng Yang, Andrew N. Lane, Christopher J. Ricketts, Carole Sourbier, Ming-Hui Wei, Brian M. Shuch, Lisa S. Pike, Min Wu, Tracey Ann Rouault, László G. Boros et al. · 2013 · PLoS ONE
98. Exploring cancer metabolism using stable isotope-resolved metabolomics (SIRM)
    Ronald C. Bruntz, Andrew N. Lane, Richard M. Higashi, Teresa W.‐M. Fan · 2017 · Journal of Biological Chemistry
99. Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
    Raffaella Iurlaro, Clara Lucía León‐Annicchiarico, Cristina Muñoz‐Pinedo · 2014 · Methods in enzymology on CD-ROM/Methods in enzymology
100. SF2312 is a natural phosphonate inhibitor of enolase
     Leonard, Paul G, Satani, Nikunj, Maxwell, David, Lin, Yu-Hsi, Hammoudi, Naima, Peng, Zhenghong, Pisaneschi, Federica, Link, Todd M, Lee, Gilbert R, Sun, Duoli et al. · 2016 · Nature Chemical Biology